Richard Pietras to Tumor Cells, Cultured
This is a "connection" page, showing publications Richard Pietras has written about Tumor Cells, Cultured.
Connection Strength
0.320
-
Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression. Oncogene. 2002 Apr 25; 21(18):2805-14.
Score: 0.048
-
Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor. Endocrine. 2001 Nov; 16(2):73-81.
Score: 0.047
-
Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene. 2001 Sep 06; 20(39):5420-30.
Score: 0.046
-
Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Cancer Res. 1999 Mar 15; 59(6):1347-55.
Score: 0.039
-
Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs. Oncogene. 1998 Oct 29; 17(17):2235-49.
Score: 0.038
-
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene. 1995 Jun 15; 10(12):2435-46.
Score: 0.030
-
Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene. 1994 Jul; 9(7):1829-38.
Score: 0.028
-
Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer. J Thorac Oncol. 2013 Mar; 8(3):270-8.
Score: 0.026
-
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells. Oncogene. 1999 Oct 28; 18(44):6050-62.
Score: 0.010
-
The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells. Oncogene. 1997 Jul 31; 15(5):537-47.
Score: 0.009